News
The main implication of our study is support for incorporating quadruplet regimens into new guidelines for the management of transplant-ineligible patients newly diagnosed multiple myeloma,” the ...
The “early promising clinical outcomes” provide a strong basis for further investigation of upright image-guided adaptive proton therapy, according to researchers.
An analysis of more than 13 million EHR notes revealed evidence suggesting racial bias in how doctors document patient credibility.
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ifinatamab deruxtecan (I-DXd) for the treatment of adults with extensive-stage small cell lung cancer (ES-SCLC ...
“he introduction of effective cancer innovations increased population-level health among patients with advanced lung cancer and melanoma but also widened the survival gap across county-level income ...
Only patients who received rituximab, ipilimumab plus nivolumab, and trastuzumab plus pertuzumab had infusion-related reactions in the real-world cohort.
Subspecialization in oncology is increasing in the United States, but it varies across cancer types and regions, data suggest.
The FDA has granted fast track designation to HLD-0915 for the treatment of metastatic castration-resistant prostate cancer.
The ASPR must update its 2022 list of 86 essential medicines and provide a plan to store and maintain a 6-month supply of APIs for drugs on the updated list, the order states.
Fifty-four percent of Americans surveyed said they drink alcohol — the lowest rate Gallup has recorded in nearly 90 years of tracking.
Two researchers describe their experiences with cancer research funding cuts due to the Trump administration’s policies and actions.
Patient comorbidities, dual-eligibility status, and area-level poverty were the strongest contributing factors to the disparities observed between Black and White patients, researchers found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results